Jiangsu Qichen New Materials Co., Ltd. acquired 24.9% stake in Jiangsu Wannianchang Pharmaceutical Co., Ltd. from Nantong Jinghua Pharmaceutical Co., Ltd. for CNY 69.4 million.
September 28, 2021
Share
Jiangsu Qichen New Materials Co., Ltd. entered into agreement to acquire 24.9% stake in Jiangsu Wannianchang Pharmaceutical Co., Ltd. from Nantong Jinghua Pharmaceutical Co., Ltd. (SZSE:002349) for CNY 69.4 million on September 28, 2021.
Jiangsu Qichen New Materials Co., Ltd. completed the acquisition of 24.9% stake in Jiangsu Wannianchang Pharmaceutical Co., Ltd. from Nantong Jinghua Pharmaceutical Co., Ltd. (SZSE:002349) on September 28, 2021.
JINGHUA PHARMACEUTICAL GROUP CO., LTD., formerly NANTONG JINGHUA PHARMACEUTICAL CO., LTD., is a China-based company, principally engaged in the research and development, production and distribution of Chinese patent drugs, pharm ingredients and intermediates and chemical intermediates. The Company is also engaged in the provision of traditional Chinese medicinal materials and Chinese herbal pieces, among others. The Company primarily provides tablets, capsules, pills, granules, injections, powder, syrup, healthcare products, beverages and chemical intermediates, among others. The Company offers Chinese patent medicines, such as Wangshi Baochiwan pills and Jidesheng tablets. Its bulk drugs include phenobarbitone and fluorouracil. The Company distributes its products in domestic and overseas markets.
JINGHUA PHARMACEUTICAL GROUP CO., LTD. 